Global Gene Editing Market Growth (Status and Outlook) 2024-2030

Global Gene Editing Market Growth (Status and Outlook) 2024-2030

According to this study, the global Gene Editing market size will reach US$ 5251.8 million by 2030.

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.

Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Editing market by product type, application, key players and key regions and countries.

Segmentation by product type:
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system

Segmentation by Application:
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Thermo Fisher Scientific
Merck
Horizo​​n Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.